An intensive new adjuvant chemoimmunotherapy program containing 5 fluorouracil (5 FU), adriamycin (AD), cyclophosphamide (CYT), and BCG (FAC BCG) for operable breast cancer

A. Buzdar, J. Gutterman, G. Blumenschein

Research output: Contribution to journalArticlepeer-review

Original languageEnglish (US)
Pages (from-to)No. C-187
JournalProceedings of the American Association for Cancer Research
Volumevol. 18
StatePublished - 1977

ASJC Scopus subject areas

  • General Medicine

Cite this